Health risks associated with the consumption of AGEs
Palimeri S, Palioura E, Diamanti-Kandarakis E (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - September 1, 2015 Category: Endocrinology Source Type: research

Electromyographic activity and insulin resistance
Micussi MT, Freitas RP, Angelo PH, Soares EM, Lemos TM, Maranhão TM (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - August 28, 2015 Category: Endocrinology Source Type: research

Kinin receptors as targets for obesity
Morais RL, Silva ED, Sales VM, Filippelli-Silva R, Mori MA, Bader M, Pesquero JB (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - August 26, 2015 Category: Endocrinology Source Type: research

Lixisenatide improves human islet grafts
Yang C, Loehn M, Jurczyk A, Przewozniak N, Leehy L, Herrera PL, Shultz LD, Greiner DL, Harlan DM, Bortell R (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - August 20, 2015 Category: Endocrinology Source Type: research

Dulaglutide – a novel GLP-1 receptor agonist
Gurung T, Shyangdan DS, O’Hare JP, Waugh N (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - August 10, 2015 Category: Endocrinology Source Type: research

Metabolic abnormalities in pituitary adenoma patients
Zheng X, Li S, Zhang WH, Yang H (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - August 5, 2015 Category: Endocrinology Source Type: research

Immunization of AGE modified albumin inhibits diabetic nephropathy
Mashitah MW, Azizah N, Samsu N, Indra MR, Bilal M, Yunisa MV, Arisanti AD (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - August 3, 2015 Category: Endocrinology Source Type: research

Sitagliptin and adiponectin-dependent anti-thrombotic effect
Omoto S, Taniura T, Nishizawa T, Tamaki T, Shouzu A,Nomura S (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - July 26, 2015 Category: Endocrinology Source Type: research

Burden of obesity in the EU5
Gupta S, Richard L, Forsythe A (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - July 21, 2015 Category: Endocrinology Source Type: research

T2DM development and CV safety requirements
Yang F, Stewart M, Ye J, DeMets D (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - July 19, 2015 Category: Endocrinology Source Type: research

Potential glycemic overtreatment in patients ≥75 years with T2DM and RI
Penfornis A, Fiquet B, Blicklé JF, Dejager S (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - July 3, 2015 Category: Endocrinology Source Type: research

Epigenetic and developmental influences on metabolic syndrome
Smith CJ, Ryckman KK (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - June 29, 2015 Category: Endocrinology Source Type: research

Role of canagliflozin metformin combination
Fleming JW, Fleming LW, Davis CS (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - June 25, 2015 Category: Endocrinology Source Type: research

Diabetinol® and glycemic control
Evans M, Judy WV, Wilson D, Rumberger JA, Guthrie N (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - June 25, 2015 Category: Endocrinology Source Type: research

Weight loss after bariatric surgery
McGrice M, Don Paul K (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - June 22, 2015 Category: Endocrinology Source Type: research

Bariatric surgery for diabetic patients
Raffaelli M, Sessa L, Mingrone G, Bellantone R (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - June 8, 2015 Category: Endocrinology Source Type: research

Exenatide QW integrated safety analysis
MacConell L, Gurney K, Malloy J, Zhou M, Kolterman O (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - May 18, 2015 Category: Endocrinology Source Type: research

Leucine and PDE5 inhibitor interaction
Fu L, Li F, Bruckbauer A, Cao Q, Cui X, Wu R, Shi H, Xue B, Zemel MB (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - May 5, 2015 Category: Endocrinology Source Type: research

Health-related quality of life and diabetes
Sepúlveda E, Poínhos R, Constante M, Pais-Ribeiro J, Freitas P, Carvalho D (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - April 29, 2015 Category: Endocrinology Source Type: research

Development of NAFLD scoring system among adult medical check up
Lesmana CRA, Pakasi LS, Inggriani S, Aidawati ML, Lesmana LA (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - April 23, 2015 Category: Endocrinology Source Type: research

Vildagliptin in diabetic patients during Ramadan fasting
Aziz KMA (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - April 16, 2015 Category: Endocrinology Source Type: research

Saroglitazar for treatment of hypertriglyceridemia current evidence
Sosale A, Saboo B, Sosale B (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - April 15, 2015 Category: Endocrinology Source Type: research

DM and risk factors in HIV infected individuals
Mohammed AE, Shenkute TY, Gebisa WC (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - April 14, 2015 Category: Endocrinology Source Type: research

Mechanisms of diabetic ß cell glucotoxicity
Wu J, Yan LJ (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - April 1, 2015 Category: Endocrinology Source Type: research

Eprosartan in Canadian hypertensives with diabetes
Petrella RJ, Gill DP, Berrou JP (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - March 23, 2015 Category: Endocrinology Source Type: research

Anagliptin in the treatment of type 2 diabetes
Nishio S, Abe M, Ito H (Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy)
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - March 17, 2015 Category: Endocrinology Source Type: research